Genetica
- Company typePrivate
- Founded2020
- HeadquartersLakewood, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
Genetica firmographics
Firmographics- Name
- Genetica
- Legal name
- Genetica
- Website
- https://getgenetica.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Genetica industry classification
Industry- Product category
- AI-driven Biotechnology / Drug Development Platform
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- akta.pro primary industry
- AAV Vector Gene Therapy Developers (HLAAACAA)
- akta.pro secondary industries
- Genetic & Genomic Rare Disease Therapeutics (HLAIAIAA), Neurology/CNS Gene Therapies (HLAAACAH)
Keywords
Where Genetica is headquartered
LocationHeadquarters
- HQ city
- Lakewood
- HQ country
- United States
- HQ region
- North America
Markets served
Genetica business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure
Genetica product offering
Product offeringCore offering
Genetica is a Vietnamese AI-driven biotechnology company developing an AI platform applied to gene therapy precision and drug development. The platform aims to shorten drug development timelines (claimed up to 70%) and improve accuracy in gene therapy applications, supported by collaborations with Stanford University and US-standard laboratory operations in Vietnam.
Product overview
Genetica is a biotechnology company focused on AI-driven gene therapy precision and drug development. The company collaborates with Stanford University and operates US-standard laboratories in Vietnam. No specific named products or modules are detailed in the available source data.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- AI can shorten drug development time by up to 70%
- +1 more outcomes
Companies that use Genetica
Customer profileSegments1 record
Ideal customer profiles1 record
Genetica technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Genetica partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and flagship.
- Stanford UniversitycoreGenetica has existing collaborations with Stanford University, demonstrating Vietnam's capability to build a regional-scale biohub with international academic partnerships in biotechnology research and development.
- US-standard LaboratoriescoreGenetica maintains collaborations with US-standard laboratories, showcasing Vietnam's capability to build a regional-scale biohub meeting international quality standards for biotechnology research.
- NvidiaflagshipThe National Innovation Centre (NIC) directed to issue an introduction letter to Genetica to facilitate partnerships with Nvidia for AI infrastructure support in the planned Vietnam biohub initiative.
- GoogleflagshipThe National Innovation Centre (NIC) directed to issue an introduction letter to Genetica to facilitate partnerships with Google for cloud and AI infrastructure support in the planned Vietnam biohub initiative.
- MicrosoftflagshipThe National Innovation Centre (NIC) directed to issue an introduction letter to Genetica to facilitate partnerships with Microsoft for AI and cloud infrastructure support in the planned Vietnam biohub initiative.
Scale indicators2 records
Recent moves6 records
Expansion highlights5 records
Genetica competitors and assessment
Company assessmentDirect peers
- Schrödinger: Computational platform combining physics-based simulation with AI for drug discovery and materials; directly comparable as an AI-driven molecular design company serving pharma.
- Insitro: AI-driven drug discovery and gene therapy platform that combines machine learning with biology to accelerate therapeutic development, directly comparable to Genetica's AI-for-gene-therapy premise.
- Atomwise: AI-driven small molecule drug discovery using deep learning on molecular structures, comparable to Genetica as a peer AI-bio platform pursuing pharmaceutical partnerships.
- Recursion Pharmaceuticals: Operates an AI-enabled high-throughput biology platform to discover and develop medicines at scale, the most direct large-scale peer to Genetica's AI-drug-development thesis.
- BenevolentAI: Applies AI to biomedical knowledge graphs for drug discovery and precision medicine, directly comparable to Genetica's AI-for-precision-medicine positioning.
Emerging players
- EvolutionaryScale: Frontier AI models for biology, comparable to Genetica as a peer leveraging large-scale AI infrastructure for biological discovery and protein engineering.
- Owkin: AI applied to biomedical data and precision medicine, partially overlapping with Genetica's AI-precision-medicine focus but with a stronger emphasis on federated clinical data.
- XtalPi: Asia-based AI and quantum physics platform for drug discovery, comparable to Genetica as a regionally rooted AI-bio player pursuing global pharma customers.
- Cradle Bio: Generative AI platform for protein and biologics design, partially comparable to Genetica where AI is used to design or optimize therapeutic candidates.
Broad incumbents
- Tempus AI: Large AI-driven precision medicine platform combining genomics, clinical data, and AI models, comparable to Genetica in the precision-medicine category though much broader in scope.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Genetica social profiles
Digital presenceGenetica financial estimates
Financial estimateRevenue estimate
Valuation estimate
Genetica leadership team
Management profileNumber of profiles
Profiles1 record
Genetica funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Genetica M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Genetica
What does Genetica do?
Genetica is a Vietnamese AI-driven biotechnology company developing an AI platform applied to gene therapy precision and drug development. The platform aims to shorten drug development timelines (claimed up to 70%) and improve accuracy in gene therapy applications, supported by collaborations with Stanford University and US-standard laboratory operations in Vietnam.
When was Genetica founded?
Genetica was founded in 2020. It employs 1 to 10 people.
Where is Genetica based?
Genetica is headquartered in Lakewood, United States, in the North America region.
Who are Genetica's main competitors?
Direct peers on record are Schrödinger, Insitro, Atomwise, Recursion Pharmaceuticals and BenevolentAI. Emerging players are EvolutionaryScale, Owkin, XtalPi and Cradle Bio. Tempus AI is listed as a broad incumbent.
Does Genetica have an API?
No public API is recorded for Genetica.
What industry is Genetica in?
Genetica's product category is AI-driven Biotechnology / Drug Development Platform. Its primary akta.pro industry code is HLAAACAA, AAV Vector Gene Therapy Developers, with a secondary code of HLAIAIAA, Genetic & Genomic Rare Disease Therapeutics. Its NAICS code is 541714.